Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-18-064025

President and CEO sold 24,337 shares at $9.37 ($228,026)

  • President and CEO acquired 89,337 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Chan Phillip P. President and CEO 2018-12-07 Option exercise +89,337 $2.10 $187,608 527,618 D: show line 1 in the form
Chan Phillip P. President and CEO 2018-12-07 Sale −24,337 $9.37 $228,026 503,281 D: show line 2 in the form
Open-market sales · 24,337 sh · avg $9.37 · $228,026

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Chan Phillip P. President and CEO 2018-12-07 Option exercise · Non-Statutory Stock Option (right to buy) +89,337 0 D: show line 3 in the form
Loading xslF345X03/tv508949_4.xml…